tanning drug melanotan II Synthetic Art Print by Molekuul / Science Photo Library Melanotan 2 - Injectable Peptide

Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis

In the SURMOUNT-1 trial, participants without diabetes lost an average of 15-22% of their body weight over 72 weeks, depending on the dose (5-15mg)

We know you might have questions or concerns, and our qualified health care professionals can give you the personalized guidance and support you need

During dose escalation (first 24 weeks), monitor blood pressure and heart rate at 0, 1, 2, and 4 hours post-injection to capture peak cardiovascular effects

Lutein helps maintain healthy vision by improving contrast sensitivity, reducing glare and enhancing overall eye health

First-Trimester Prospective Study for the Detection of Pregnancies at a High Risk of Preeclampsia